Cargando…
Virus‐like particles for vaccination against cancer
Active immunotherapy of cancer aims to treat the disease by inducing effective cellular and humoral immune responses. Virus‐like particle‐based vaccines have evolved dramatically over the last few decades, greatly reducing morbidity and mortality of several infectious diseases and expectedly prevent...
Autores principales: | Mohsen, Mona O., Speiser, Daniel E., Knuth, Alexander, Bachmann, Martin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916610/ https://www.ncbi.nlm.nih.gov/pubmed/31456339 http://dx.doi.org/10.1002/wnan.1579 |
Ejemplares similares
-
The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
por: Mohsen, Mona O., et al.
Publicado: (2020) -
Virus-like particle vaccinology, from bench to bedside
por: Mohsen, Mona O., et al.
Publicado: (2022) -
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018) -
Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020) -
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)